SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-001868
Filing Date
2021-01-07
Accepted
2021-01-07 09:13:22
Documents
42
Period of Report
2021-01-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm211875d1_8k.htm   iXBRL 8-K 27263
2 EXHIBIT 99.1 tm211875d1_ex99-1.htm EX-99.1 42005
6 GRAPHIC tm211875d1_ex99-1img001.jpg GRAPHIC 264462
7 GRAPHIC tm211875d1_ex99-1img002.jpg GRAPHIC 189056
8 GRAPHIC tm211875d1_ex99-1img003.jpg GRAPHIC 136583
9 GRAPHIC tm211875d1_ex99-1img004.jpg GRAPHIC 175595
10 GRAPHIC tm211875d1_ex99-1img005.jpg GRAPHIC 111768
11 GRAPHIC tm211875d1_ex99-1img006.jpg GRAPHIC 150859
12 GRAPHIC tm211875d1_ex99-1img007.jpg GRAPHIC 297247
13 GRAPHIC tm211875d1_ex99-1img008.jpg GRAPHIC 145542
14 GRAPHIC tm211875d1_ex99-1img009.jpg GRAPHIC 220663
15 GRAPHIC tm211875d1_ex99-1img010.jpg GRAPHIC 164089
16 GRAPHIC tm211875d1_ex99-1img011.jpg GRAPHIC 113311
17 GRAPHIC tm211875d1_ex99-1img012.jpg GRAPHIC 181308
18 GRAPHIC tm211875d1_ex99-1img013.jpg GRAPHIC 139396
19 GRAPHIC tm211875d1_ex99-1img014.jpg GRAPHIC 254955
20 GRAPHIC tm211875d1_ex99-1img015.jpg GRAPHIC 227050
21 GRAPHIC tm211875d1_ex99-1img016.jpg GRAPHIC 121148
22 GRAPHIC tm211875d1_ex99-1img017.jpg GRAPHIC 149910
23 GRAPHIC tm211875d1_ex99-1img018.jpg GRAPHIC 205517
24 GRAPHIC tm211875d1_ex99-1img019.jpg GRAPHIC 167971
25 GRAPHIC tm211875d1_ex99-1img020.jpg GRAPHIC 150469
26 GRAPHIC tm211875d1_ex99-1img021.jpg GRAPHIC 272964
27 GRAPHIC tm211875d1_ex99-1img022.jpg GRAPHIC 115802
28 GRAPHIC tm211875d1_ex99-1img023.jpg GRAPHIC 181573
29 GRAPHIC tm211875d1_ex99-1img024.jpg GRAPHIC 173475
30 GRAPHIC tm211875d1_ex99-1img025.jpg GRAPHIC 159363
31 GRAPHIC tm211875d1_ex99-1img026.jpg GRAPHIC 155801
32 GRAPHIC tm211875d1_ex99-1img027.jpg GRAPHIC 189057
33 GRAPHIC tm211875d1_ex99-1img028.jpg GRAPHIC 182187
34 GRAPHIC tm211875d1_ex99-1img029.jpg GRAPHIC 264462
  Complete submission text file 0001104659-21-001868.txt   7481473

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mnlo-20210107.xsd EX-101.SCH 3214
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnlo-20210107_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnlo-20210107_pre.xml EX-101.PRE 22729
35 EXTRACTED XBRL INSTANCE DOCUMENT tm211875d1_8k_htm.xml XML 3712
Mailing Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38356 | Film No.: 21513112
SIC: 2834 Pharmaceutical Preparations